Yanbing Li
-
- Diabetes Treatment and Management 32
- Diabetes Management and Research 32
- Thyroid Cancer Diagnosis and Treatment 18
- Cancer Research top 2%
- Cancer-related molecular mechanisms research 17
- Molecular Biology top 5%
- Metabolism, Diabetes, and Cancer 30
- RNA modifications and cancer 15
- Nephrology top 5%
-
- Pancreatic function and diabetes 23
-
- Diabetes and associated disorders 14
Yanbing Li
250 papers receiving 4.4k citations
Peers
Comparison fields: 5 of 158
- Endocrinology, Diabetes and Metabolism 1.5k
- Cancer Research 823
- Molecular Biology 1.8k
- Nephrology 162
- Pathology and Forensic Medicine 333
Countries citing papers authored by Yanbing Li
This map shows the geographic impact of Yanbing Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanbing Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanbing Li more than expected).
Fields of papers citing papers by Yanbing Li
This network shows the impact of papers produced by Yanbing Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanbing Li. The network helps show where Yanbing Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yanbing Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 2 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 17 | |
| 7 | 2023 | 4 | |
| 8 | 2022 | 10 | |
| 9 | 2022 | 24 | |
| 10 | 2022 | 20 | |
| 11 | 2021 | 20 | |
| 12 | 2021 | 15 | |
| 13 | 2021 | 81 | |
| 14 | 2021 | 5 | |
| 15 | 2020 | 3 | |
| 16 | 2020 | 2 | |
| 17 | 2020 | 25 | |
| 18 | 2020 | 5 | |
| 19 | 2019 | 3 | |
| 20 | 2017 | 13 |
About Yanbing Li
Yanbing Li is a scholar working on Endocrinology, Diabetes and Metabolism, Cancer Research and Pathology and Forensic Medicine, having authored 266 papers that have together received 4.4k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (32 papers), Diabetes Management and Research (32 papers), Metabolism, Diabetes, and Cancer (30 papers), Pancreatic function and diabetes (23 papers), Thyroid Cancer Diagnosis and Treatment (18 papers), Cancer-related molecular mechanisms research (17 papers), RNA modifications and cancer (15 papers) and Diabetes and associated disorders (14 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.5k citations), Cancer Research (823 citations) and Molecular Biology (1.8k citations). Yanbing Li has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Haipeng Xiao, Zhimin Huang, Xiaopei Cao, Hongyu Guan, Shuang Yu, Zhihong Liao, Hai Li, Liehua Liu, Shubin Hong and Hongyu Guan. Their work appears in journals such as The Journal of Clinical Endocrinology & Metabolism, Diabetes Research and Clinical Practice, Journal of Diabetes Investigation, Journal of Diabetes and Thyroid.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.